Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-31

FDA Approved: CLONAZEPAM — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved Advagen Pharma Ltd's supplemental application for clonazepam (generic) under ANDA075468, authorizing an additional clonazepam product. This is a su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)